PHIO PHARMACEUTICALS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
PHIO PHARMACEUTICALS CORP. (PHIO) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 750.00 thousand shares as of 2018-12-31, per its 10-K filed 2019-03-27.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2019-03-27
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 750.00K shares.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 125.00K shares.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 1.25M shares.
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 5.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2018-12-31 | 750.00K shares 10-K · filed 2019-03-27 |
| 2017-12-31 | 125.00K shares 10-K · filed 2018-03-26 |
| 2016-12-31 | 1.25M shares 10-K · filed 2017-03-30 |
| 2015-12-31 | 5.00M shares 10-K · filed 2016-03-30 |
| 2014-12-31 | 5.00M shares 10-K · filed 2015-03-30 |
| 2013-12-31 | 5.00M shares 10-K · filed 2014-03-28 |
| 2012-12-31 | 90.00M shares 10-K · filed 2013-03-29 |
| 2012-09-30 | 90.00M shares 10-Q · filed 2012-11-13 |
| 2012-06-30 | 90.00M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |